IEFA vs XLV: Complete Comparison
iShares Core MSCI EAFE ETF vs Health Care Select Sector SPDR Fund — overlap, correlation, performance & risk analysis
Visual Overlap
Price Performance
Historical price comparison over 3M
📈Performance Comparison
⚔️Head-to-Head Comparison
🏆 XLV wins this comparison
Key Factors
▶Additional Metrics (3)
Bottom line: XLV wins with better expense ratio and number of holdings. Consider XLV for your portfolio, but IEFA is still a solid choice if you prefer its specific advantages.
Detailed Overlap Analysis
0 shared holdings representing 0.0% portfolio overlap
Top Shared Holdings
| # | Stock | IEFA Weight | XLV Weight | Overlap |
|---|
Top Holdings Only in IEFA
Unique to IEFA
| Symbol | Name | Weight |
|---|---|---|
| NOVO-B.CO | Novo Nordisk A/S | 2.15% |
| ASML.AS | ASML Holding NV | 2.08% |
| NESN.SW | Nestle SA | 1.62% |
| AZN.L | AstraZeneca plc | 1.45% |
| SHEL.L | Shell plc | 1.38% |
Top Holdings Only in XLV
Unique to XLV
| Symbol | Name | Weight |
|---|---|---|
| LLY | LLY | 14.33% |
| JNJ | JNJ | 8.84% |
| ABBV | ABBV | 7.23% |
| UNH | UNH | 5.38% |
| MRK | MRK | 4.44% |
Price Correlation
How We Calculate Overlap
We use the minimum weight method with normalization to calculate portfolio overlap:
Overlap = Σ min(weightA, weightB) for each shared holdingNormalization: Holdings weights are normalized to sum to 100% before comparison. This ensures accurate overlap calculations even when analyzing partial holdings data (e.g., top 50 positions).
Conservative approach: We consider only the smaller allocation for each shared position, giving you a realistic view of true portfolio overlap.
📊 This analysis is based on publicly available holdings data. For the most current and complete holdings information, please visit the official ETF provider websites.
Want deeper analysis on IEFA or XLV?
Complement your EigenDex analysis with these research tools.
Some links may be affiliate links. We may earn a commission at no extra cost to you. This helps support EigenDex as a free tool. We only recommend tools we believe provide genuine value to investors.